Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Razadyne (Galantamine Hydrobromide) ER (Formerly Reminyl)
Company:  Johnson & Johnson Pharmaceutical Research
Application No.: 021615
Approval Date: 12/22/2004


Date created: December 052005

Back to Top     Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.